ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: FR-PO042

Can a Patient with Membranoproliferative Glomerulonephritis (MPGN) Following Anabolic Testosterone and Supplement Abuse Benefit from Glucocorticoid Treatment?

Session Information

Category: Nephrology Education

  • 1302 Fellows and Residents Case Reports

Authors

  • Rowaiye, Olumide Olatubosun, Wroclaw Medical University, Wroclaw, Poland
  • Donizy, Piotr, Wroclaw Medical University, Wroclaw, Poland
  • Kusztal, Mariusz, Wroclaw Medical University, Wroclaw, Poland
  • Penar, Jozef, Wroclaw Medical University, Wroclaw, Poland
  • Halon, Agnieszka, Wroclaw Medical University, Wroclaw, Poland
  • Krajewska, Magdalena, Wroclaw Medical University, Wroclaw, Poland
  • Klinger, Marian, Wroclaw Medical University, Wroclaw, Poland
Background

The use of anabolic androgenic steroids (AAS) have been associated with a number of adverse effects; however, the occurrence of MPGN is uncommon. We describe a rare case of MPGN following anabolic testosterone and supplement abuse.

Methods

a 22-yr-old man with no significant past medical history presents with high serum creatinine (3.62 mg/dl), edema and gross hematuria. He admits that 8 months prior to presentation, he started a regimen of regular intensive physical workouts and OTC supplements (7 kg/month of a product containing 60.7 g of protein and 177.8 g of complex carbs). He used i.m. injections of testosterone enanthate (250 mg every 5 days for 3 months). Last testosterone dose was 3 months prior to presentation.
On examination, he was found to have BP 150/80 mmHg and lower extremity edema. Urinalysis revealed 2+ blood, active urinary sediments. Urine protein excretion was 4.6 g/day while serum albumin was 2.8 g/dl. Serological studies were negative for ANA, anti-dsDNA, ANCA, anti-GBM, HBV, HCV and HIV. CRP was normal. Serum C3 factor was low (0.17 g/l) while C4 was normal. Ultrasound showed enlarged kidneys: right -12.9 cm, left - 13.1 cm. Renal biopsy was performed which revealed active MPGN with segmental fibrinoid necrosis in 5 glomeruli but no crescents (fig 1). Also moderate tubulo-interstitial nephritis (TIN I/II°) (fig 2) was seen. Immunohistochemistry showed moderately intense mesangial IgG deposits in most glomeruli with a few mesangial IgM deposits; C3 was negative. Patient was treated with i.v. pulse methylprednisolone and i.v. diuretics which resulted in serum creatinine level of 1.77 mg/dl and disappearance of the edema. On follow-up visit 4 weeks later, serum creatinine was 1.38 mg/dl and patient continued to further improve.

Conclusion

Patients with MPGN following AAS and supplement abuse, with features of rapidly progressive glomerulonephritis may benefit from glucocorticoid treatment.